Curis
CRIS
#10302
Rank
ยฃ8.14 M
Marketcap
ยฃ0.63
Share price
-1.38%
Change (1 day)
-77.82%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -ยฃ24.78 Million

According to Curis's latest financial reports the company's current earnings are ยฃ11.65 Million. In 2024 the company made an earning of -ยฃ31.33 Million, an increase over its 2023 earnings that were of -ยฃ33.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ24.78 Million-20.89%
2024 -ยฃ31.33 Million-5.77%
2023 -ยฃ33.25 Million-13.1%
2022 -ยฃ38.26 Million27.52%
2021 -ยฃ30 Million65.09%
2020 -ยฃ18.17 Million-9.1%
2019 -ยฃ19.99 Million-4.73%
2018 -ยฃ20.98 Million-41.95%
2017 -ยฃ36.14 Million-14.37%
2016 -ยฃ42.21 Million3.55%
2015 -ยฃ40.76 Million271.52%
2014 -ยฃ10.97 Million76.64%
2013 -ยฃ6.22 Million
2011 -ยฃ5.28 Million27.76%
2010 -ยฃ4.13 Million-43.87%
2009 -ยฃ7.36 Million-23.44%
2008 -ยฃ9.61 Million56.66%
2007 -ยฃ6.14 Million-16.71%
2006 -ยฃ7.37 Million-36.92%
2005 -ยฃ11.68 Million156.25%
2004 -ยฃ4.56 Million-37.24%
2003 -ยฃ7.26 Million-93.34%
2002 -ยฃ0.11 Billion86.79%
2001 -ยฃ58.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.67 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.88 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ45.32 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.63 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.19 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ18.14 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA